PHILADELPHIA, Sept 18, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- eResearchTechnology, Inc.
(eRT), (Nasdaq: ERES), a leading provider of centralized ECG and eClinical
technology, ePRO and other services to the pharmaceutical, biotechnology,
medical device and related industries, announced today that Dr. Michael J.
McKelvey, the Company's President and Chief Executive Officer, and Keith
Schneck, the Company's Chief Financial Officer, are scheduled to present at
the UBS Global Life Sciences Conference at 3:30 p.m. EDT on September 23rd,
2008 at the Grand Hyatt Park Avenue Hotel in New York, New York.

Interested parties may access the presentation by visiting the Company's
corporate website at www.ert.com or www.ibb.ubs.com. The webcast will be
available via replay for 90 days.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com)
is a provider of technology and services to the pharmaceutical, biotechnology
and medical device industries on a global basis. The company is a market
leader in providing centralized core-diagnostic electrocardiographic (ECG)
technology and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technology and services to
streamline the clinical trials process by enabling its customers to automate
the collection, analysis, and distribution of clinical data in all phases of
clinical development.

Statements included in this release may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Such statements, including but not limited to 2008 financial
guidance, involve a number of risks and uncertainties such as the company's
ability to obtain new contracts and accurately estimate net revenues due to
uncertain regulatory guidance, variability in size, scope and duration of
projects, and internal issues at the sponsoring client, integration of
acquisitions, competitive factors, technological development, and market
demand. As a result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors that could
affect the company's financial results can be found in the company's Reports
on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The
company undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or otherwise.

SOURCE eResearchTechnology, Inc.

http://www.ert.com

Copyright (C) 2008 PR Newswire. All rights reserved